Skip to main content


We're creating a new version of this page. See preview

  • Short report
  • Open Access

Primary bilateral adrenal B-cell lymphoma associated with EBV and JCV infection

  • 1Email author,
  • 1,
  • 2,
  • 2 and
  • 1
Infectious Agents and Cancer20094:1

  • Received: 10 September 2008
  • Accepted: 15 January 2009
  • Published:


Primary lymphoma of the adrenal gland is a rare and highly aggressive disease, with only a few reports in the literature. The pathogenesis is unknown, but detection of Epstein Barr virus (EBV) genome sequences and gene expression in some cases of primary adrenal lymphomas suggested the virus might be a causative agent of the malignancy. While investigating the presence of genome sequences of oncogenic viruses in a large series of adrenal tumors, both EBV and JC polyomavirus (JCV) DNA sequences were detected in a diffuse large primary bilateral B-cell non-Hodgkin lymphoma of the adrenal gland, which was diagnosed only at postmortem examination in a 77 year-old woman with incidentally discovered adrenal masses and primary adrenal insufficiency. The presence of both EBV and JCV genome sequences suggests the relevance of EBV and JCV coinfection in the pathogenesis of this rare form of B-cell lymphoma.


  • Epstein Barr Virus
  • Adrenal Mass
  • Adrenocortical Carcinoma
  • Primary Adrenal Insufficiency
  • Primary Adrenal Lymphoma


Primary lymphoma of the adrenal gland is a rare and highly aggressive disease, with only a few reports in the literature [13]. It generally affects elderly individuals, especially those with a history of cancer, HIV infection, or autoimmune disorders, and, in about 50% of cases, it presents with symptoms of adrenal insufficiency due to bilateral adrenal involvement. Histologically, the most common type of primary adrenal lymphomas is diffuse large B-cell lymphoma [3]. Treatment with chemotherapy according to the CHOP-regimen (cyclophosphamide, doxorubicin, vincristine, prednisone) alone or in combination with rituximab has led complete or partial remission is some patients, even though prognosis remains poor with death occurring within one year after diagnosis [35]. The pathogenesis is unknown, but detection of Epstein Barr virus (EBV) genome sequences and gene expression in 9 out of 20 cases of primary adrenal lymphomas suggested the virus might be the causative agent of the malignancy [6]. While investigating the presence of genome sequences of oncogenic viruses in a large series of adrenal tumors and their potential association with malignancy [7], both EBV and JC polyomavirus (JCV) DNA sequences were detected in the case of primary bilateral adrenal B-cell lymphoma we are reporting here.

The patient was a 77-yr woman with bilateral adrenal masses which were incidentally discovered at abdominal ultrasonography performed for dispepsia and weigth loss. The past history of the patients was unremarkable except hypertension. Computed tomography (CT)-scan confirmed the presence of bilateral (right adrenal mass maximum diameter, 5 cm; left adrenal mass maximum diameter, 7 cm) solid and heterogeneous adrenal masses which probably infiltrated the liver. Brain and bone CT-scans were negative. Laboratory evaluation demonstrated the presence of anemia, increased erythrosedimentation rate, and the presence of monoclonal G immunoglobulins, while autoantibodies testing was negative. Endocrine evaluation demonstrated primary adrenal insufficiency, since all adrenal steroids were low and adrenocorticotropin levels were markedly elevated. Replacement therapy with cortisone was started, resulting in immediate improvement of symptoms. Repeated chest-abdominal CT-scan performed after 3 months showed increased mass size with areas of colliquation and the presence of left pleural effusion. Bilateral nonvisualization at adrenal scintiscan suggested the presence of malignant or space-occupying adrenal lesions [8]. Fine needle aspiration biopsy was not performed because bilateral adrenocortical carcinoma or metastases were suspected based on CT-scan and scintigraphic appearance. At 5 months from diagnosis, the patient died because of advanced disease. Postmortem examination revealed bilateral involvement of adrenal glands by encapsulated masses with a solid, friable, grayish-white cut surface and extensive necrosis. Microscopic features consisted of large transformed lymphoid cells with pleomorphic vesicular nuclei with prominent nucleoli (Fig. 1a). Upon immunohistochemical analysis, the neoplastic cells expressed the B cell marker CD20 (Fig. 1b). A diagnosis of diffuse large B-cell non-Hodgkin lymphoma was made. To investigate whether oncogenic viruses were involved in the disease, both left and right adrenal masses were examined for the presence of all human herpesviruses and polyomaviruses by quantitative real-time PCR, as reported [7]. EBV DNA was present at high titre (about 100 genome copies/cell) and JCV DNA at lower titre (about 0.1 genome copy/cell) in both adrenal masses. EBV genotyping by PCR amplification of the EBNA-2 and EBNA-3B genes [9] demonstrated EBV type 1, while sequencing of the JCV VP1 gene [10] classified JCV as type 1B (Fig. 2), which are the genotypes most commonly found in our Country. Moreover, PCR-amplification of both large T antigen (TAg) and the VP1 sequences suggested that the entire JCV genome was present. EBV and JCV DNA was not detected in other tissues (lymph nodes, spleen, liver, kidney). Both immunohistochemical staining and western blot analysis of JCV TAg expression in lymphoma samples, which were performed with an anti-SV40 TAg cross-reacting antibody (Calbiochem, Anti-SV40 T Antigen Ab-2, Pab416) as reported [7], gave negative results. It cannot however be excluded that lack of JCV TAg detection was due to the relatively low number of JCV-positive cells and to the poor quality of tissue samples.
Figure 1
Figure 1

a) Non-Hodgkin lymphoma and glandular structures (H & E; original magnification 400×); b) immunostaining showing neoplastic cells positive for CD20 (original magnification 400×).

Figure 2
Figure 2

Electropherogram of the JCV VP1 gene fragment sequence amplified from the primary adrenal lymphoma. PCR amplification and sequencing was performed by using the JLP-15 and JLP-16 primers reported by Agostini et al. [10]. Nucleotides that are critical for genotyping are underlined.

While EBV is a recognized causative agent of B-cell lymphomas, the association between JCV and hematologic malignancies is matter of debate. A potential implication of JCV in B-cell lymphomas is suggested by its oncogenicity in vitro and in animal models [11] and by its ability to infect B-lymphocytes [12], where it seems to cause chromosomal damage [13]. Indeed, JCV DNA and gene expression have been detected in 4 of 63 (6%) non-Hodgkin lymphomas and in 1 of 20 (5%) Hodgkin lymphomas [14], in a primary B-cell lymphoma of the central nervous system occurring in a patient with AIDS and concurrent progressive multifocal leucoencephalopathy [15], and in 22 of 27 (81%) primary B-cell lymphomas of the central nervous system, including 14 which also contained EBV DNA [16]. However, it remains unknown whether JCV has a causal role in human neoplasia. Our report of a primary adrenal B-cell lymphoma positive for both JCV and EBV DNA, even if it does not provide evidence for a causal relationship between viral infection and development of lymphoma, could support the hypothesis by Del Valle et al. [16] that JCV might act as a co-factor of EBV in B-cell transformation. However, since we did not evaluate whether the patient had systemic JCV infection before death, we cannot exclude a secondary involvement of lymphoma cells in the course of a systemic infection due to JCV reactivation in a terminally-ill patient. This is also suggested by the relatively low JCV DNA load (0.1 copies/cell) in tumor tissues.

In conclusion, we demonstrated the presence of both EBV and JCV genome sequences in a diffuse large B-cell non-Hodgkin lymphoma of the adrenal gland. Further studies in other cases are encouraged to clarify the relevance of EBV and JCV coinfection in the pathogenesis of this rare form of extranodal B-cell lymphoma.



This study was supported by grant no. RSF 271/07 from Veneto Region to Giorgio Palù.

Authors’ Affiliations

Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, I-35121 Padova, Italy
Department of Pathology, University of Padova, I-35121 Padova, Italy


  1. Wang J, Sun NC, Renslo R, Chuang CC, Tabbarah HJ, Barajas L, French SW: Clinically silent primary adrenal lymphoma: A case report and review of the literature. Am J Hematol. 1998, 58: 130-136. 10.1002/(SICI)1096-8652(199806)58:2<130::AID-AJH8>3.0.CO;2-T.PubMedView ArticleGoogle Scholar
  2. Mantzios G, Tsirigotis P, Veliou F, Boutsikakis I, Petraki L, Kolovos J, Papageorgiou S, Robos Y: Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature. Ann Hematol. 2004, 83: 460-463. 10.1007/s00277-003-0838-3.PubMedView ArticleGoogle Scholar
  3. Ozimek A, Diebold J, Linke R, Heyn J, Hallfeldt K, Mussack T: Bilateral primary adrenal non-Hodgkin's lymphoma and primary adrenocortical carcinoma – Review of the literature. Preoperative differentiation of adrenal tumors. Endocr J. 2008, 55: 625-638. 10.1507/endocrj.K08E-035.PubMedView ArticleGoogle Scholar
  4. Singh D, Kumar L, Sharma A, Vijayaraghavan M, Thulkar S, Tandon N: Adrenal involvement in non-Hodgkin's lymphoma: four cases and review of literature. Leuk Lymphoma. 2004, 45: 789-794. 10.1080/10428190310001615756.PubMedView ArticleGoogle Scholar
  5. Schreiber CS, Sakon JR, Simião FP, Tomarchio MP, Huayllas M, Pereira LC, Stella LC, Santomauro AC, Bueno SS, Fraige FF: Primary adrenal lymphoma: a case series study. Ann Hematol. 2008, 87: 859-861. 10.1007/s00277-008-0492-x.PubMedView ArticleGoogle Scholar
  6. Ohsawa M, Tomita Y, Hashimoto M, Yasunaga Y, Kanno H, Aozasa K: Malignant lymphoma of the adrenal gland: its possible correlation with the Epstein-Barr virus. Mod Pathol. 1996, 9: 534-543.PubMedGoogle Scholar
  7. Barzon L, Trevisan M, Masi G, Pacenti M, Sinigaglia A, Macchi V, Porzionato A, De Caro R, Favia G, Iacobone M, Palù G: Detection of polyomaviruses and herpesviruses in human adrenal tumors. Oncogene. 2008, 27: 857-864. 10.1038/sj.onc.1210699.PubMedView ArticleGoogle Scholar
  8. Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macrì C, Boscaro M: Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab. 1998, 83: 55-62. 10.1210/jc.83.1.55.PubMedGoogle Scholar
  9. Lee HS, Chang MS, Yang H-K, Lee BL, Kim WH: Epstein-Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res. 2004, 0: 1698-1705. 10.1158/1078-0432.CCR-1122-3.View ArticleGoogle Scholar
  10. Agostini HT, Deckhut A, Jobes DV, Girones R, Schlunck G, Prost MG, Frias C, Pérez-Trallero E, Ryschkewitsch CF, Stoner GL: Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol. 2001, 82: 1221-1331.PubMedView ArticleGoogle Scholar
  11. White MK, Khalili K: Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer. 2005, 41: 2537-2548. 10.1016/j.ejca.2005.08.019.PubMedView ArticleGoogle Scholar
  12. Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO: JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol. 1996, 70: 7004-7012.PubMedPubMed CentralGoogle Scholar
  13. Neel JV, Major EO, Awa AA, Glover T, Burgess A, Traub R, Curfman B, Satoh C: Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncogenesis. Proc Natl Acad Sci USA. 1996, 93: 2690-2695. 10.1073/pnas.93.7.2690.PubMedPubMed CentralView ArticleGoogle Scholar
  14. Hernández-Losa J, Fedele CG, Pozo F, Tenorio A, Fernández V, Castellví J, Parada C, Ramón y Cajal S: Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer. 2005, 103: 293-298. 10.1002/cncr.20801.PubMedView ArticleGoogle Scholar
  15. Gallia GL, DelValle L, Laine C, Curtis M, Khalili K: Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen. Mol Pathol. 2001, 54: 354-359. 10.1136/mp.54.5.354.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Del Valle L, Enam S, Lara C, Miklossy J, Khalili K, Gordon J: Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol. 2004, 78: 3462-3669. 10.1128/JVI.78.7.3462-3469.2004.PubMedPubMed CentralView ArticleGoogle Scholar


© Barzon et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.